Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

InspireMD Inc (NSPR) USD0.0001

Sell:$0.41 Buy:$0.43 Change: $0.0258 (5.97%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
Sell:$0.41
Buy:$0.43
Change: $0.0258 (5.97%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
Sell:$0.41
Buy:$0.43
Change: $0.0258 (5.97%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Contact details

Address:
4 Menorat Hamaor St.
TEL AVIV-YAFO
6744832
Israel
Telephone:
+1 (857) 4536553
Website:
www.inspiremd.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NSPR
ISIN:
US45779A8532
Market cap:
$48.31 million
Shares in issue:
49.26 million
Sector:
Health Care Supplies
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Paul Stuka
    Chairman of the Board
  • Marvin Slosman
    Chief Executive Officer, Director
  • Isaac Blech
    Independent Vice Chairman of the Board
  • Craig Shore
    Chief Financial Officer, Chief Administrative Officer, Treasurer and Secretary
  • Agustin Gago
    Executive Vice President, Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.